SCHEMBL2073156

SCHEMBL2073156

O=C1OCCc2nc(-c3cccc(Cl)c3)sc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ NPC1 O15118 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ POLB P06746 2/20 0.41
▸ TRPM8 Q7Z2W7 1/20 0.39
▸ GRM5 P41594 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ AVPR1B P47901 2/20 0.37
▸ PIM1 P11309 1/20 0.36
▸ NOTUM Q6P988 1/20 0.36
▸ MAPT P10636 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ HRH3 Q9Y5N1 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2074075 0.85 ALDH1A1 (0.42) KMT2ANPC1RAB9ASMN1; SMN2POLB
SCHEMBL2073946 0.81 RAB9A (0.40) NPC1RAB9ASMN1; SMN2POLBLMNA
SCHEMBL2076299 0.77 ALOX5 (0.44) GRM5
SCHEMBL12154272 0.77 ALOX5 (0.44) KMT2ANPC1RAB9ASMN1; SMN2TRPM8
SCHEMBL2072998 0.74 TNKS2 (0.42) KMT2ANPC1RAB9ASMN1; SMN2POLB
SCHEMBL2075217 0.74 ALOX5 (0.48) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL23024871 0.69 KMT2A (0.43) KMT2AADORA3NPC1RAB9ASMN1; SMN2
SCHEMBL2096169 0.67 KMT2A (0.61) KMT2AADORA3NPC1RAB9ASMN1; SMN2
SCHEMBL15933590 0.67 PDCD1 (0.50) KMT2AADORA3NPC1RAB9ASMN1; SMN2
SCHEMBL11473824 0.65 KMT2A (0.58) KMT2AADORA3NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902356-B2 Thiazolopyridinone derivates as MCH receptor antagonists ELI LILLY AND COMPANY (US) 2011-03-08 — — US disclosed
US-7902356-B2 Thiazolopyridinone derivates as MCH receptor antagonists ELI LILLY AND COMPANY (US) 2011-03-08 — — US disclosed
US-7902356-B2 Thiazolopyridinone derivates as MCH receptor antagonists ELI LILLY AND COMPANY (US) 2011-03-08 — — US disclosed
EP-1828207-B1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2009-10-28 — — EP disclosed
EP-1828207-B1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2009-10-28 — — EP disclosed
US-20090233919-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY 2009-09-17 — — US disclosed
US-20090233919-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY 2009-09-17 — — US disclosed
US-20090233919-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY 2009-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233919-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS MCHR1, MCHR2, MC1R KMT2A 588/4885ADORA3 415/4885NPC1 828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback